|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:SLC45A3-AP1G2 (FusionGDB2 ID:83322) |
Fusion Gene Summary for SLC45A3-AP1G2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SLC45A3-AP1G2 | Fusion gene ID: 83322 | Hgene | Tgene | Gene symbol | SLC45A3 | AP1G2 | Gene ID | 85414 | 8906 |
| Gene name | solute carrier family 45 member 3 | adaptor related protein complex 1 subunit gamma 2 | |
| Synonyms | IPCA-2|IPCA-6|IPCA-8|IPCA6|PCANAP2|PCANAP6|PCANAP8|PRST | G2AD | |
| Cytomap | 1q32.1 | 14q11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | solute carrier family 45 member 3prostate cancer associated protein 2prostate cancer associated protein 6prostate cancer associated protein 8prostate cancer-associated gene 2prostate cancer-associated gene 6prostate cancer-associated gene 8prostein | AP-1 complex subunit gamma-like 2adaptor related protein complex 1 gamma 2 subunitclathrin-associated/assembly/adaptor protein, large, gamma-2gamma2-adaptin | |
| Modification date | 20200313 | 20200320 | |
| UniProtAcc | . | O75843 | |
| Ensembl transtripts involved in fusion gene | ENST00000367145, ENST00000460934, | ENST00000397120, ENST00000556277, ENST00000308724, | |
| Fusion gene scores | * DoF score | 21 X 18 X 4=1512 | 19 X 9 X 9=1539 |
| # samples | 33 | 20 | |
| ** MAII score | log2(33/1512*10)=-2.19592020997526 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(20/1539*10)=-2.94392132655349 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SLC45A3 [Title/Abstract] AND AP1G2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | SLC45A3(205626979)-AP1G2(24037279), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across SLC45A3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across AP1G2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PRAD | TCGA-CH-5768-01A | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
Top |
Fusion Gene ORF analysis for SLC45A3-AP1G2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000367145 | ENST00000397120 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
| 5CDS-intron | ENST00000367145 | ENST00000556277 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
| 5CDS-intron | ENST00000460934 | ENST00000397120 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
| 5CDS-intron | ENST00000460934 | ENST00000556277 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
| In-frame | ENST00000367145 | ENST00000308724 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
| In-frame | ENST00000460934 | ENST00000308724 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000460934 | SLC45A3 | chr1 | 205626979 | - | ENST00000308724 | AP1G2 | chr14 | 24037279 | - | 5746 | 2448 | 3192 | 5561 | 789 |
| ENST00000367145 | SLC45A3 | chr1 | 205626979 | - | ENST00000308724 | AP1G2 | chr14 | 24037279 | - | 6639 | 3341 | 4085 | 6454 | 789 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000460934 | ENST00000308724 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - | 0.007004999 | 0.99299496 |
| ENST00000367145 | ENST00000308724 | SLC45A3 | chr1 | 205626979 | - | AP1G2 | chr14 | 24037279 | - | 0.01778448 | 0.9822155 |
Top |
Fusion Genomic Features for SLC45A3-AP1G2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SLC45A3-AP1G2 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:205626979/chr14:24037279) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | AP1G2 |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: May function in protein sorting in late endosomes or multivesucular bodies (MVBs). {ECO:0000269|PubMed:9733768}.; FUNCTION: (Microbial infection) Involved in MVB-assisted maturation of hepatitis B virus (HBV). {ECO:0000269|PubMed:16867982, ECO:0000269|PubMed:17553870}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 455_458 | 1015 | 554.0 | Compositional bias | Note=Poly-Pro |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 120_140 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D4 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 161_181 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D5 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 198_218 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D6 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 19_39 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D1 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 275_295 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D7 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 323_343 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D8 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 353_373 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D9 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 382_402 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D10 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 522_542 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D11 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 52_72 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D2 |
| Hgene | SLC45A3 | chr1:205626979 | chr14:24037279 | ENST00000367145 | - | 5 | 5 | 88_108 | 1015 | 554.0 | Transmembrane | Helical%3B Name%3D3 |
| Tgene | AP1G2 | chr1:205626979 | chr14:24037279 | ENST00000308724 | -1 | 21 | 665_780 | 68 | 786.0 | Domain | GAE | |
| Tgene | AP1G2 | chr1:205626979 | chr14:24037279 | ENST00000397120 | 0 | 22 | 665_780 | 0 | 786.0 | Domain | GAE | |
| Tgene | AP1G2 | chr1:205626979 | chr14:24037279 | ENST00000308724 | -1 | 21 | 369_379 | 68 | 786.0 | Region | Note=Essential for ubiquitin-binding | |
| Tgene | AP1G2 | chr1:205626979 | chr14:24037279 | ENST00000397120 | 0 | 22 | 369_379 | 0 | 786.0 | Region | Note=Essential for ubiquitin-binding |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for SLC45A3-AP1G2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >83322_83322_1_SLC45A3-AP1G2_SLC45A3_chr1_205626979_ENST00000367145_AP1G2_chr14_24037279_ENST00000308724_length(transcript)=6639nt_BP=3341nt AAGGAAGGGGGGGCGGAACCAGCCTGCACGCGCTGGCTCCGGGTGACAGCCGCGCGCCTCGGCCAGGATCTGAGTGATGAGACGTGTCCC CACTGAGGTGCCCCACAGCAGCAGGTGTTGAGCATGGGCTGAGAAGCTGGACCGGCACCAAAGGGCTGGCAGAAATGGGCGCCTGGCTGA TTCCTAGGCAGTTGGCGGCAGCAAGGAGGAGAGGCCGCAGCTTCTGGAGCAGAGCCGAGACGAAGCAGTTCTGGAGTGCCTGAACGGCCC CCTGAGCCCTACCCGCCTGGCCCACTATGGTCCAGAGGCTGTGGGTGAGCCGCCTGCTGCGGCACCGGAAAGCCCAGCTCTTGCTGGTCA ACCTGCTAACCTTTGGCCTGGAGGTGTGTTTGGCCGCAGGCATCACCTATGTGCCGCCTCTGCTGCTGGAAGTGGGGGTAGAGGAGAAGT TCATGACCATGGTGCTGGGCATTGGTCCAGTGCTGGGCCTGGTCTGTGTCCCGCTCCTAGGCTCAGCCAGTGACCACTGGCGTGGACGCT ATGGCCGCCGCCGGCCCTTCATCTGGGCACTGTCCTTGGGCATCCTGCTGAGCCTCTTTCTCATCCCAAGGGCCGGCTGGCTAGCAGGGC TGCTGTGCCCGGATCCCAGGCCCCTGGAGCTGGCACTGCTCATCCTGGGCGTGGGGCTGCTGGACTTCTGTGGCCAGGTGTGCTTCACTC CACTGGAGGCCCTGCTCTCTGACCTCTTCCGGGACCCGGACCACTGTCGCCAGGCCTACTCTGTCTATGCCTTCATGATCAGTCTTGGGG GCTGCCTGGGCTACCTCCTGCCTGCCATTGACTGGGACACCAGTGCCCTGGCCCCCTACCTGGGCACCCAGGAGGAGTGCCTCTTTGGCC TGCTCACCCTCATCTTCCTCACCTGCGTAGCAGCCACACTGCTGGTGGCTGAGGAGGCAGCGCTGGGCCCCACCGAGCCAGCAGAAGGGC TGTCGGCCCCCTCCTTGTCGCCCCACTGCTGTCCATGCCGGGCCCGCTTGGCTTTCCGGAACCTGGGCGCCCTGCTTCCCCGGCTGCACC AGCTGTGCTGCCGCATGCCCCGCACCCTGCGCCGGCTCTTCGTGGCTGAGCTGTGCAGCTGGATGGCACTCATGACCTTCACGCTGTTTT ACACGGATTTCGTGGGCGAGGGGCTGTACCAGGGCGTGCCCAGAGCTGAGCCGGGCACCGAGGCCCGGAGACACTATGATGAAGGCGTTC GGATGGGCAGCCTGGGGCTGTTCCTGCAGTGCGCCATCTCCCTGGTCTTCTCTCTGGTCATGGACCGGCTGGTGCAGCGATTCGGCACTC GAGCAGTCTATTTGGCCAGTGTGGCAGCTTTCCCTGTGGCTGCCGGTGCCACATGCCTGTCCCACAGTGTGGCCGTGGTGACAGCTTCAG CCGCCCTCACCGGGTTCACCTTCTCAGCCCTGCAGATCCTGCCCTACACACTGGCCTCCCTCTACCACCGGGAGAAGCAGGTGTTCCTGC CCAAATACCGAGGGGACACTGGAGGTGCTAGCAGTGAGGACAGCCTGATGACCAGCTTCCTGCCAGGCCCTAAGCCTGGAGCTCCCTTCC CTAATGGACACGTGGGTGCTGGAGGCAGTGGCCTGCTCCCACCTCCACCCGCGCTCTGCGGGGCCTCTGCCTGTGATGTCTCCGTACGTG TGGTGGTGGGTGAGCCCACCGAGGCCAGGGTGGTTCCGGGCCGGGGCATCTGCCTGGACCTCGCCATCCTGGATAGTGCCTTCCTGCTGT CCCAGGTGGCCCCATCCCTGTTTATGGGCTCCATTGTCCAGCTCAGCCAGTCTGTCACTGCCTATATGGTGTCTGCCGCAGGCCTGGGTC TGGTCGCCATTTACTTTGCTACACAGGTAGTATTTGACAAGAGCGACTTGGCCAAATACTCAGCGTAGAAAACTTCCAGCACATTGGGGT GGAGGGCCTGCCTCACTGGGTCCCAGCTCCCCGCTCCTGTTAGCCCCATGGGGCTGCCGGGCTGGCCGCCAGTTTCTGTTGCTGCCAAAG TAATGTGGCTCTCTGCTGCCACCCTGTGCTGCTGAGGTGCGTAGCTGCACAGCTGGGGGCTGGGGCGTCCCTCTCCTCTCTCCCCAGTCT CTAGGGCTGCCTGACTGGAGGCCTTCCAAGGGGGTTTCAGTCTGGACTTATACAGGGAGGCCAGAAGGGCTCCATGCACTGGAATGCGGG GACTCTGCAGGTGGATTACCCAGGCTCAGGGTTAACAGCTAGCCTCCTAGTTGAGACACACCTAGAGAAGGGTTTTTGGGAGCTGAATAA ACTCAGTCACCTGGTTTCCCATCTCTAAGCCCCTTAACCTGCAGCTTCGTTTAATGTAGCTCTTGCATGGGAGTTTCTAGGATGAAACAC TCCTCCATGGGATTTGAACATATGAAAGTTATTTGTAGGGGAAGAGTCCTGAGGGGCAACACACAAGAACCAGGTCCCCTCAGCCCACAG CACTGTCTTTTTGCTGATCCACCCCCCTCTTACCTTTTATCAGGATGTGGCCTGTTGGTCCTTCTGTTGCCATCACAGAGACACAGGCAT TTAAATATTTAACTTATTTATTTAACAAAGTAGAAGGGAATCCATTGCTAGCTTTTCTGTGTTGGTGTCTAATATTTGGGTAGGGTGGGG GATCCCCAACAATCAGGTCCCCTGAGATAGCTGGTCATTGGGCTGATCATTGCCAGAATCTTCTTCTCCTGGGGTCTGGCCCCCCAAAAT GCCTAACCCAGGACCTTGGAAATTCTACTCATCCCAAATGATAATTCCAAATGCTGTTACCCAAGGTTAGGGTGTTGAAGGAAGGTAGAG GGTGGGGCTTCAGGTCTCAACGGCTTCCCTAACCACCCCTCTTCTCTTGGCCCAGCCTGGTTCCCCCCACTTCCACTCCCCTCTACTCTC TCTAGGACTGGGCTGATGAAGGCACTGCCCAAAATTTCCCCTACCCCCAACTTTCCCCTACCCCCAACTTTCCCCACCAGCTCCACAACC CTGTTTGGAGCTACTGCAGGACCAGAAGCACAAAGTGCGGTTTCCCAAGCCTTTGTCCATCTCAGCCCCCAGAGTATATCTGTGCTTGGG GAATCTCACACAGAAACTCAGGAGCACCCCCTGCCTGAGCTAAGGGAGGTCTTATCTCTCAGGGGGGGTTTAAGTGCCGTTTGCAATAAT GTCGTCTTATTTATTTAGCGGGGTGAATATTTTATACTGTAAGTGAGCAATCAGAGTATAATGTTTATGGTGACAAAATTAAAGGCTTTC TTATATGTTTAAAAAAAAATATATTAATAAAAAAGTTCAAAAAAGGGGGGGGATTGTCATCTCCTTTGGGGTGCGATGGCTTCAAATCCA AACTGAGGCTCTCCGGGTGGTAAGGATGTGCGAGGAGGCCTCTTGAAGAACTCCAGGCCTATCATGCTGTCTCTCCGCTAAAGCCTGAGG CCCGAGGTCAGAGGATTCAGGAAGGCTCTGCAGTCGGCCCAGGAGGGCGGGGTCCCGTGGTGGAGGCGGGGAGAGGGAAGGACCGCACGG AGCACCAACCCCTGCTCGGCCCCGTACCAGGAAGCGCTGGGGGGCAGAGGAGCGGAGTTGAGGCAGAAGCCAGGTGAGGCTGGAGTCCTG GGGTAGGCAGGCTGTCGCTGCCGCTGCCGCTGCCTGAGATGGAAATCGGGGGAGGAAGCTCGCGGAAGAAACAGCGGAGGGTCGTGGAAA AAAAAGCAATGGCTGAGCTAGGGATGGGGTACCAGGTAGGGGGAGGAAACGGTAGAGAGAAATAGGTGGGGCTCCCGCGCATGCTCAATA GGAAGGGGCGCCGGTGGGGTGCGGACGCATGCGTAGTGGGCTTCTCGGGCGGTGGGGTGGGCGCGGAATTTGGAGACCCACTTCGGGAAA GGTAAAATGCGGGCGCAATTTTAGGGTACCTGTGGGACCCGGGCTCTTAGGGTCTTGACACAGGACGGGCCTGGGCCGAAAGCCCAGGCA CGCCCGACCAGAGAGTGTTTCTCCACTCCCGGACTCTGCCAGTCAGGATGGTGGTGCCTTCGCTGAAGCTTCAGGACCTCATCGAAGAGA TTCGCGGGGCCAAGACTCAGGCCCAGGAGCGGGAGGTGATCCAAAAGGAGTGTGCCCACATCCGGGCCTCCTTCCGCGACGGGGACCCAG TGCACAGGCACCGGCAGCTGGCCAAACTGCTCTACGTCCACATGTTGGGCTACCCCGCCCACTTTGGACAGATGGAGTGCCTGAAACTGA TCGCCTCCTCCAGATTCACAGACAAGAGGGTGGGCTACCTGGGGGCCATGCTTCTATTGGATGAGAGGCACGATGCCCACCTGCTCATTA CCAACAGCATCAAGAATGACCTGAGCCAGGGGATTCAGCCAGTACAAGGCCTGGCCTTGTGCACTTTGAGCACCATGGGCTCTGCTGAGA TGTGCCGAGACCTGGCCCCAGAGGTGGAGAAACTGCTCCTGCAGCCCAGTCCCTACGTGCGCAAGAAGGCTATTCTGACTGCAGTGCACA TGATCCGGAAGGTCCCTGAACTCTCCAGTGTCTTCCTCCCACCCTGTGCCCAACTGCTTCATGAGCGTCACCATGGCATCCTGCTGGGCA CCATCACGCTGATCACGGAGCTCTGCGAACGAAGCCCTGCAGCCCTCAGGCACTTCCGAAAGGTGGTACCCCAGCTGGTACACATCCTCC GGACTCTGGTGACAATGGGATACTCCACAGAACACAGCATATCTGGAGTCAGCGACCCCTTCCTGCAGGTCCAGATACTTCGTCTGCTTC GGATCCTGGGCCGGAACCACGAGGAGAGCAGTGAGACCATGAATGACTTGCTGGCCCAGGTGGCCACTAACACGGACACCAGCCGAAATG CCGGAAATGCGGTCCTGTTTGAGACAGTACTCACCATCATGGATATCCGCTCTGCAGCTGGCCTACGGGTTCTAGCTGTCAACATTCTTG GTCGCTTCCTACTCAACAGTGACAGGAACATTAGGTATGTAGCCCTGACATCACTGCTTCGACTGGTGCAGTCTGATCACAGTGCTGTGC AGCGGCATCGGCCCACTGTGGTGGAATGTCTACGGGAAACTGATGCCTCCCTCAGCCGGAGAGCCCTGGAACTAAGCCTGGCTCTGGTAA ATAGCTCCAATGTGCGAGCCATGATGCAAGAGCTGCAGGCCTTTCTGGAGTCCTGCCCTCCTGACCTACGGGCTGACTGTGCCTCAGGCA TCCTGCTGGCTGCAGAGAGGTTTGCTCCAACCAAACGCTGGCACATAGACACCATCCTGCATGTGCTGACAACGGCGGGCACCCATGTGC GGGATGATGCAGTGGCCAACCTGACCCAGCTGATTGGGGGGGCCCAGGAGCTACATGCCTACTCTGTGCGCCGCCTCTACAATGCCCTGG CAGAAGACATTTCCCAGCAACCACTGGTGCAGGTGGCAGCCTGGTGCATTGGGGAGTATGGGGACCTCCTGCTGGCAGGGAACTGCGAGG AGATTGAGCCCCTTCAGGTGGACGAAGAGGAAGTGCTGGCATTGCTGGAAAAGGTGCTGCAGTCCCACATGTCCCTGCCAGCCACTCGAG GATATGCCCTCACAGCCCTCATGAAGCTCAGCACTCGCCTCTGTGGGGACAACAACCGCATCCGCCAGGTGGTGTCCATCTACGGGAGCT GCTTGGACGTGGAGCTGCAGCAGCGGGCTGTGGAGTATGACACACTCTTCCGGAAATACGACCACATGAGGGCTGCCATCCTGGAAAAAA TGCCTCTTGTGGAGCGAGATGGCCCTCAGGCTGATGAGGAAGCAAAGGAAAGCAAAGAAGCAGCCCAGCTTTCAGAAGCAGCCCCAGTGC CCACAGAGCCCCAGGCCTCACAGCTCCTGGATCTGCTAGATCTCCTGGATGGGGCTTCTGGGGATGTCCAGCATCCTCCCCATCTGGACC CCTCCCCAGGAGGTGCCCTGGTACACCTGCTTGACCTTCCCTGTGTACCTCCACCCCCAGCTCCCATCCCAGATCTCAAAGTGTTTGAGC GTGAGGGAGTACAGCTGAATCTGTCTTTCATTCGACCCCCTGAAAACCCTGCTTTGCTGTTAATCACCATCACTGCCACCAACTTCTCAG AGGGTGATGTCACCCATTTCATCTGCCAGGCTGCTGTGCCCAAGAGTCTCCAGCTGCAGCTGCAGGCCCCCAGTGGGAACACAGTTCCAG CTCGGGGTGGCCTTCCTATCACCCAGCTCTTCAGAATCCTCAATCCTAACAAGGCCCCCCTGCGGCTAAAGCTGCGCCTCACCTACGACC ACTTTCACCAGTCGGTGCAGGAGATCTTTGAGGTGAACAACTTGCCTGTGGAATCGTGGCAGTAACTGTCTCCACTCACAGCCTGAAATT CTCCTGTGTCCCAAACCCCAGGGGGCCCCAGCAGCTTCGAACCTACACCTGAGGGCTACCAGCAGGTGGCGCTCTGGCTTTGCACTGCAA >83322_83322_1_SLC45A3-AP1G2_SLC45A3_chr1_205626979_ENST00000367145_AP1G2_chr14_24037279_ENST00000308724_length(amino acids)=789AA_BP= MPVRMVVPSLKLQDLIEEIRGAKTQAQEREVIQKECAHIRASFRDGDPVHRHRQLAKLLYVHMLGYPAHFGQMECLKLIASSRFTDKRVG YLGAMLLLDERHDAHLLITNSIKNDLSQGIQPVQGLALCTLSTMGSAEMCRDLAPEVEKLLLQPSPYVRKKAILTAVHMIRKVPELSSVF LPPCAQLLHERHHGILLGTITLITELCERSPAALRHFRKVVPQLVHILRTLVTMGYSTEHSISGVSDPFLQVQILRLLRILGRNHEESSE TMNDLLAQVATNTDTSRNAGNAVLFETVLTIMDIRSAAGLRVLAVNILGRFLLNSDRNIRYVALTSLLRLVQSDHSAVQRHRPTVVECLR ETDASLSRRALELSLALVNSSNVRAMMQELQAFLESCPPDLRADCASGILLAAERFAPTKRWHIDTILHVLTTAGTHVRDDAVANLTQLI GGAQELHAYSVRRLYNALAEDISQQPLVQVAAWCIGEYGDLLLAGNCEEIEPLQVDEEEVLALLEKVLQSHMSLPATRGYALTALMKLST RLCGDNNRIRQVVSIYGSCLDVELQQRAVEYDTLFRKYDHMRAAILEKMPLVERDGPQADEEAKESKEAAQLSEAAPVPTEPQASQLLDL LDLLDGASGDVQHPPHLDPSPGGALVHLLDLPCVPPPPAPIPDLKVFEREGVQLNLSFIRPPENPALLLITITATNFSEGDVTHFICQAA -------------------------------------------------------------- >83322_83322_2_SLC45A3-AP1G2_SLC45A3_chr1_205626979_ENST00000460934_AP1G2_chr14_24037279_ENST00000308724_length(transcript)=5746nt_BP=2448nt ATCTCTGCTTGCGGTTTCAGGAAGGCCTCTGGCTGCTCTAGGAGTCTGATCAGAGTCGTTGCCCCAGTTTGACAGAAGGAAAGGCGGAGC TTATTCAAAGTCTAGAGGGAGTGGAGGAGTTAAGGCTGGATTTCAGATCTGCCTGGTTCCAGCCGCAGTGTGCCCTCTGCTCCCCCAACG ACTTTCCAAATAATCTCACCAGCGCCTTCCAGCTCAGGCGTCCTAGAAGCGTCTTGAAGCCTATGGCCAGCTGTCTTTGTGTTCCCTCTC ACCCGCCTGTCCTCACAGCTGAGACTCCCAGGAAACCTTCAGACTACCTTCCTCTGCCTTCAGCAAGGGGCGTTGCCCACATTCTCTGAG GGCGTTCGGATGGGCAGCCTGGGGCTGTTCCTGCAGTGCGCCATCTCCCTGGTCTTCTCTCTGGTCATGGACCGGCTGGTGCAGCGATTC GGCACTCGAGCAGTCTATTTGGCCAGTGTGGCAGCTTTCCCTGTGGCTGCCGGTGCCACATGCCTGTCCCACAGTGTGGCCGTGGTGACA GCTTCAGCCGCCCTCACCGGGTTCACCTTCTCAGCCCTGCAGATCCTGCCCTACACACTGGCCTCCCTCTACCACCGGGAGAAGCAGGTG TTCCTGCCCAAATACCGAGGGGACACTGGAGGTGCTAGCAGTGAGGACAGCCTGATGACCAGCTTCCTGCCAGGCCCTAAGCCTGGAGCT CCCTTCCCTAATGGACACGTGGGTGCTGGAGGCAGTGGCCTGCTCCCACCTCCACCCGCGCTCTGCGGGGCCTCTGCCTGTGATGTCTCC GTACGTGTGGTGGTGGGTGAGCCCACCGAGGCCAGGGTGGTTCCGGGCCGGGGCATCTGCCTGGACCTCGCCATCCTGGATAGTGCCTTC CTGCTGTCCCAGGTGGCCCCATCCCTGTTTATGGGCTCCATTGTCCAGCTCAGCCAGTCTGTCACTGCCTATATGGTGTCTGCCGCAGGC CTGGGTCTGGTCGCCATTTACTTTGCTACACAGGTAGTATTTGACAAGAGCGACTTGGCCAAATACTCAGCGTAGAAAACTTCCAGCACA TTGGGGTGGAGGGCCTGCCTCACTGGGTCCCAGCTCCCCGCTCCTGTTAGCCCCATGGGGCTGCCGGGCTGGCCGCCAGTTTCTGTTGCT GCCAAAGTAATGTGGCTCTCTGCTGCCACCCTGTGCTGCTGAGGTGCGTAGCTGCACAGCTGGGGGCTGGGGCGTCCCTCTCCTCTCTCC CCAGTCTCTAGGGCTGCCTGACTGGAGGCCTTCCAAGGGGGTTTCAGTCTGGACTTATACAGGGAGGCCAGAAGGGCTCCATGCACTGGA ATGCGGGGACTCTGCAGGTGGATTACCCAGGCTCAGGGTTAACAGCTAGCCTCCTAGTTGAGACACACCTAGAGAAGGGTTTTTGGGAGC TGAATAAACTCAGTCACCTGGTTTCCCATCTCTAAGCCCCTTAACCTGCAGCTTCGTTTAATGTAGCTCTTGCATGGGAGTTTCTAGGAT GAAACACTCCTCCATGGGATTTGAACATATGAAAGTTATTTGTAGGGGAAGAGTCCTGAGGGGCAACACACAAGAACCAGGTCCCCTCAG CCCACAGCACTGTCTTTTTGCTGATCCACCCCCCTCTTACCTTTTATCAGGATGTGGCCTGTTGGTCCTTCTGTTGCCATCACAGAGACA CAGGCATTTAAATATTTAACTTATTTATTTAACAAAGTAGAAGGGAATCCATTGCTAGCTTTTCTGTGTTGGTGTCTAATATTTGGGTAG GGTGGGGGATCCCCAACAATCAGGTCCCCTGAGATAGCTGGTCATTGGGCTGATCATTGCCAGAATCTTCTTCTCCTGGGGTCTGGCCCC CCAAAATGCCTAACCCAGGACCTTGGAAATTCTACTCATCCCAAATGATAATTCCAAATGCTGTTACCCAAGGTTAGGGTGTTGAAGGAA GGTAGAGGGTGGGGCTTCAGGTCTCAACGGCTTCCCTAACCACCCCTCTTCTCTTGGCCCAGCCTGGTTCCCCCCACTTCCACTCCCCTC TACTCTCTCTAGGACTGGGCTGATGAAGGCACTGCCCAAAATTTCCCCTACCCCCAACTTTCCCCTACCCCCAACTTTCCCCACCAGCTC CACAACCCTGTTTGGAGCTACTGCAGGACCAGAAGCACAAAGTGCGGTTTCCCAAGCCTTTGTCCATCTCAGCCCCCAGAGTATATCTGT GCTTGGGGAATCTCACACAGAAACTCAGGAGCACCCCCTGCCTGAGCTAAGGGAGGTCTTATCTCTCAGGGGGGGTTTAAGTGCCGTTTG CAATAATGTCGTCTTATTTATTTAGCGGGGTGAATATTTTATACTGTAAGTGAGCAATCAGAGTATAATGTTTATGGTGACAAAATTAAA GGCTTTCTTATATGTTTAAAAAAAAATATATTAATAAAAAAGTTCAAAAAAGGGGGGGGATTGTCATCTCCTTTGGGGTGCGATGGCTTC AAATCCAAACTGAGGCTCTCCGGGTGGTAAGGATGTGCGAGGAGGCCTCTTGAAGAACTCCAGGCCTATCATGCTGTCTCTCCGCTAAAG CCTGAGGCCCGAGGTCAGAGGATTCAGGAAGGCTCTGCAGTCGGCCCAGGAGGGCGGGGTCCCGTGGTGGAGGCGGGGAGAGGGAAGGAC CGCACGGAGCACCAACCCCTGCTCGGCCCCGTACCAGGAAGCGCTGGGGGGCAGAGGAGCGGAGTTGAGGCAGAAGCCAGGTGAGGCTGG AGTCCTGGGGTAGGCAGGCTGTCGCTGCCGCTGCCGCTGCCTGAGATGGAAATCGGGGGAGGAAGCTCGCGGAAGAAACAGCGGAGGGTC GTGGAAAAAAAAGCAATGGCTGAGCTAGGGATGGGGTACCAGGTAGGGGGAGGAAACGGTAGAGAGAAATAGGTGGGGCTCCCGCGCATG CTCAATAGGAAGGGGCGCCGGTGGGGTGCGGACGCATGCGTAGTGGGCTTCTCGGGCGGTGGGGTGGGCGCGGAATTTGGAGACCCACTT CGGGAAAGGTAAAATGCGGGCGCAATTTTAGGGTACCTGTGGGACCCGGGCTCTTAGGGTCTTGACACAGGACGGGCCTGGGCCGAAAGC CCAGGCACGCCCGACCAGAGAGTGTTTCTCCACTCCCGGACTCTGCCAGTCAGGATGGTGGTGCCTTCGCTGAAGCTTCAGGACCTCATC GAAGAGATTCGCGGGGCCAAGACTCAGGCCCAGGAGCGGGAGGTGATCCAAAAGGAGTGTGCCCACATCCGGGCCTCCTTCCGCGACGGG GACCCAGTGCACAGGCACCGGCAGCTGGCCAAACTGCTCTACGTCCACATGTTGGGCTACCCCGCCCACTTTGGACAGATGGAGTGCCTG AAACTGATCGCCTCCTCCAGATTCACAGACAAGAGGGTGGGCTACCTGGGGGCCATGCTTCTATTGGATGAGAGGCACGATGCCCACCTG CTCATTACCAACAGCATCAAGAATGACCTGAGCCAGGGGATTCAGCCAGTACAAGGCCTGGCCTTGTGCACTTTGAGCACCATGGGCTCT GCTGAGATGTGCCGAGACCTGGCCCCAGAGGTGGAGAAACTGCTCCTGCAGCCCAGTCCCTACGTGCGCAAGAAGGCTATTCTGACTGCA GTGCACATGATCCGGAAGGTCCCTGAACTCTCCAGTGTCTTCCTCCCACCCTGTGCCCAACTGCTTCATGAGCGTCACCATGGCATCCTG CTGGGCACCATCACGCTGATCACGGAGCTCTGCGAACGAAGCCCTGCAGCCCTCAGGCACTTCCGAAAGGTGGTACCCCAGCTGGTACAC ATCCTCCGGACTCTGGTGACAATGGGATACTCCACAGAACACAGCATATCTGGAGTCAGCGACCCCTTCCTGCAGGTCCAGATACTTCGT CTGCTTCGGATCCTGGGCCGGAACCACGAGGAGAGCAGTGAGACCATGAATGACTTGCTGGCCCAGGTGGCCACTAACACGGACACCAGC CGAAATGCCGGAAATGCGGTCCTGTTTGAGACAGTACTCACCATCATGGATATCCGCTCTGCAGCTGGCCTACGGGTTCTAGCTGTCAAC ATTCTTGGTCGCTTCCTACTCAACAGTGACAGGAACATTAGGTATGTAGCCCTGACATCACTGCTTCGACTGGTGCAGTCTGATCACAGT GCTGTGCAGCGGCATCGGCCCACTGTGGTGGAATGTCTACGGGAAACTGATGCCTCCCTCAGCCGGAGAGCCCTGGAACTAAGCCTGGCT CTGGTAAATAGCTCCAATGTGCGAGCCATGATGCAAGAGCTGCAGGCCTTTCTGGAGTCCTGCCCTCCTGACCTACGGGCTGACTGTGCC TCAGGCATCCTGCTGGCTGCAGAGAGGTTTGCTCCAACCAAACGCTGGCACATAGACACCATCCTGCATGTGCTGACAACGGCGGGCACC CATGTGCGGGATGATGCAGTGGCCAACCTGACCCAGCTGATTGGGGGGGCCCAGGAGCTACATGCCTACTCTGTGCGCCGCCTCTACAAT GCCCTGGCAGAAGACATTTCCCAGCAACCACTGGTGCAGGTGGCAGCCTGGTGCATTGGGGAGTATGGGGACCTCCTGCTGGCAGGGAAC TGCGAGGAGATTGAGCCCCTTCAGGTGGACGAAGAGGAAGTGCTGGCATTGCTGGAAAAGGTGCTGCAGTCCCACATGTCCCTGCCAGCC ACTCGAGGATATGCCCTCACAGCCCTCATGAAGCTCAGCACTCGCCTCTGTGGGGACAACAACCGCATCCGCCAGGTGGTGTCCATCTAC GGGAGCTGCTTGGACGTGGAGCTGCAGCAGCGGGCTGTGGAGTATGACACACTCTTCCGGAAATACGACCACATGAGGGCTGCCATCCTG GAAAAAATGCCTCTTGTGGAGCGAGATGGCCCTCAGGCTGATGAGGAAGCAAAGGAAAGCAAAGAAGCAGCCCAGCTTTCAGAAGCAGCC CCAGTGCCCACAGAGCCCCAGGCCTCACAGCTCCTGGATCTGCTAGATCTCCTGGATGGGGCTTCTGGGGATGTCCAGCATCCTCCCCAT CTGGACCCCTCCCCAGGAGGTGCCCTGGTACACCTGCTTGACCTTCCCTGTGTACCTCCACCCCCAGCTCCCATCCCAGATCTCAAAGTG TTTGAGCGTGAGGGAGTACAGCTGAATCTGTCTTTCATTCGACCCCCTGAAAACCCTGCTTTGCTGTTAATCACCATCACTGCCACCAAC TTCTCAGAGGGTGATGTCACCCATTTCATCTGCCAGGCTGCTGTGCCCAAGAGTCTCCAGCTGCAGCTGCAGGCCCCCAGTGGGAACACA GTTCCAGCTCGGGGTGGCCTTCCTATCACCCAGCTCTTCAGAATCCTCAATCCTAACAAGGCCCCCCTGCGGCTAAAGCTGCGCCTCACC TACGACCACTTTCACCAGTCGGTGCAGGAGATCTTTGAGGTGAACAACTTGCCTGTGGAATCGTGGCAGTAACTGTCTCCACTCACAGCC TGAAATTCTCCTGTGTCCCAAACCCCAGGGGGCCCCAGCAGCTTCGAACCTACACCTGAGGGCTACCAGCAGGTGGCGCTCTGGCTTTGC >83322_83322_2_SLC45A3-AP1G2_SLC45A3_chr1_205626979_ENST00000460934_AP1G2_chr14_24037279_ENST00000308724_length(amino acids)=789AA_BP= MPVRMVVPSLKLQDLIEEIRGAKTQAQEREVIQKECAHIRASFRDGDPVHRHRQLAKLLYVHMLGYPAHFGQMECLKLIASSRFTDKRVG YLGAMLLLDERHDAHLLITNSIKNDLSQGIQPVQGLALCTLSTMGSAEMCRDLAPEVEKLLLQPSPYVRKKAILTAVHMIRKVPELSSVF LPPCAQLLHERHHGILLGTITLITELCERSPAALRHFRKVVPQLVHILRTLVTMGYSTEHSISGVSDPFLQVQILRLLRILGRNHEESSE TMNDLLAQVATNTDTSRNAGNAVLFETVLTIMDIRSAAGLRVLAVNILGRFLLNSDRNIRYVALTSLLRLVQSDHSAVQRHRPTVVECLR ETDASLSRRALELSLALVNSSNVRAMMQELQAFLESCPPDLRADCASGILLAAERFAPTKRWHIDTILHVLTTAGTHVRDDAVANLTQLI GGAQELHAYSVRRLYNALAEDISQQPLVQVAAWCIGEYGDLLLAGNCEEIEPLQVDEEEVLALLEKVLQSHMSLPATRGYALTALMKLST RLCGDNNRIRQVVSIYGSCLDVELQQRAVEYDTLFRKYDHMRAAILEKMPLVERDGPQADEEAKESKEAAQLSEAAPVPTEPQASQLLDL LDLLDGASGDVQHPPHLDPSPGGALVHLLDLPCVPPPPAPIPDLKVFEREGVQLNLSFIRPPENPALLLITITATNFSEGDVTHFICQAA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SLC45A3-AP1G2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SLC45A3-AP1G2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SLC45A3-AP1G2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies